Montgomery Community Media

A Gaithersburg company currently working on a COVID-19 vaccine announced it is expanding and expects to add 400 new jobs by the end of 2024, with most of the new positions added by March of 2021, according to a news release from Gov. Larry Hogan. Novavax, a late-stage biotechnology company, intends to expand into a […]

On Thursday, Gov. Larry Hogan toured Novavax, a Gaithersburg company that is developing a COVID-19 vaccine. The vaccine candidate is currently in Phase 2 of clinical trials in the U.S., and is expected to begin Phase 3 in a few weeks. Novavax CEO Stanley Erck hopes to see results by early 2021, but said it’s […]

La empresa de biotecnología de Gaithersburg, Novavax, anunció el lunes que llegó a un acuerdo para administrar a Canadá hasta 76 millones de dosis de la vacuna COVID-19 de Novavax. En un comunicado, la compañía dijo que la vacuna se encuentra en múltiples ensayos clínicos de Fase 2 en este momento. Novavax espera finalizar un […]

Gaithersburg biotechnology company Novavax announced Monday that it has reached an agreement in principle to give Canada up to 76 million doses of Novavax’s COVID-19 vaccine.  In a statement the company said the vaccine is in multiple Phase 2 clinical trials right now. Novavax expects to finalize an agreement that would begin supplying the doses […]

The New York Times has published a coronavirus vaccine tracker that shows the progress of the more than 165 vaccines in development, and the 30 that are in human trials. The coronavirus pandemic has forced researchers to condense years of research and testing into a shorter time frame, with the goal to produce a safe […]

The Gaithersburg-based biotechnology company Novavax reported positive results Tuesday in phase 1 of its clinical trial for a potential COVID-19 vaccine. Promising news #MadeInMontgomery. https://t.co/rC2H7EkGQf — Montgomery Council (@MoCoCouncilMD) August 4, 2020 In early July, Novavax received $1.6 billion in funding as part of the federal government’s Operation Warp Speed, an initiative aiming to accelerate […]

The Tokyo-based Fujifilm Diosynth Biotechnologies joined other companies Monday in helping Gaithersburg’s Novavax produce and distribute the first batch of a potential COVID-19 vaccine to be used in clinical trials.  Novavax will be making its Covid-19 vaccine candidate with help Fujifilm Diosynth Biotechnologies, part of the $1.6 billion the Gaithersburg biotech secured from the federal […]

The heat emergency continues and the county has opened several cooling centers. It’s Tuesday, July 21, and here are five things to know in Montgomery County. 1. Council in Virtual Session: Montgomery County Council meets virtually at 9 a.m. The agenda includes a resolution in support of mailing ballots for the general election. Additionally, Councilmember […]

The Federal government recently awarded Gaithersburg-based biotech company Novavax 1.6 billion in funding to develop and distribute 100 million COVID-19 vaccines as early as the end of this year. County Cable Montgomery’s Susan Kenedy spoke with Jim Young, the Novavax Chairman of the Board, about the work being done at Novavax. He explained why the […]

Novavax—a biotechnology company located in Gaithersburg—has been awarded $1.6 billion to accelerate the development of a potential COVID-19 vaccine. The company announced Tuesday that it has been selected to participate in Operation Warp Speed. This federal government program will help cover testing, commercialization, and manufacturing of a potential COVID-19 vaccine in the United States. The program […]